NCT05114850 Retrospective Prospective Multicentric Clinical Follow up of Patients After Being Treated With TricValve®
| NCT ID | NCT05114850 |
| Status | Recruiting |
| Phase | — |
| Sponsor | P+F Products + Features GmbH |
| Condition | Tricuspid Regurgitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2022-04-20 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2022-04-20 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Retrospective prospective Multicentric clinical follow up of patients with severe tricuspid regurgitation after being treated with the TricValve® Transcatheter Bicaval Valves System.
Eligibility Criteria
Inclusion Criteria: * Successful treatment with TricValve Transcatheter Bicaval Valves System * Patient/patient's authorized legal guardian gives his consent to participate in the study and signed the corresponding inform consent Exclusion Criteria: * no exclusion criterion
Contact & Investigator
Ignacio J Amat Santos, Dr
PRINCIPAL INVESTIGATOR
Hospital Clínico Universitario de Valladolid
Frequently Asked Questions
Who can join the NCT05114850 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tricuspid Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05114850 currently recruiting?
Yes, NCT05114850 is actively recruiting participants. Contact the research team at sscheidl@pfcardiovascular.com for enrollment information.
Where is the NCT05114850 trial being conducted?
This trial is being conducted at Sankt Pölten, Austria, Vienna, Austria, Vienna, Austria, Aalst, Belgium and 11 additional locations.
Who is sponsoring the NCT05114850 clinical trial?
NCT05114850 is sponsored by P+F Products + Features GmbH. The principal investigator is Ignacio J Amat Santos, Dr at Hospital Clínico Universitario de Valladolid. The trial plans to enroll 450 participants.